Literature DB >> 19880778

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.

Ana Mozos1, Cristina Royo, Elena Hartmann, Daphne De Jong, Cristina Baró, Alexandra Valera, Kai Fu, Dennis D Weisenburger, Jan Delabie, Shih-Sung Chuang, Elaine S Jaffe, Carmen Ruiz-Marcellan, Sandeep Dave, Lisa Rimsza, Rita Braziel, Randy D Gascoyne, Francisco Solé, Armando López-Guillermo, Dolors Colomer, Louis M Staudt, Andreas Rosenwald, German Ott, Pedro Jares, Elias Campo.   

Abstract

BACKGROUND: Cyclin D1-negative mantle cell lymphoma is difficult to distinguish from other small B-cell lymphomas. The clinical and pathological characteristics of patients with this form of lymphoma have not been well defined. Overexpression of the transcription factor SOX11 has been observed in conventional mantle cell lymphoma. The aim of this study was to determine whether this gene is expressed in cyclin D1-negative mantle cell lymphoma and whether its detection may be useful to identify these tumors. DESIGN AND METHODS: The microarray database of 238 mature B-cell neoplasms was re-examined. SOX11 protein expression was investigated immunohistochemically in 12 cases of cyclin D1-negative mantle cell lymphoma, 54 cases of conventional mantle cell lymphoma, and 209 additional lymphoid neoplasms.
RESULTS: SOX11 mRNA was highly expressed in conventional and cyclin D1-negative mantle cell lymphoma and in 33% of the cases of Burkitt's lymphoma but not in any other mature lymphoid neoplasm. SOX11 nuclear protein was detected in 50 cases (93%) of conventional mantle cell lymphoma and also in the 12 cyclin D1-negative cases of mantle cell lymphoma, the six cases of lymphoblastic lymphomas, in two of eight cases of Burkitt's lymphoma, and in two of three T-prolymphocytic leukemias but was negative in the remaining lymphoid neoplasms. Cyclin D2 and D3 mRNA levels were significantly higher in cyclin D1-negative mantle cell lymphoma than in conventional mantle cell lymphoma but the protein expression was not discriminative. The clinico-pathological features and outcomes of the patients with cyclin D1-negative mantle cell lymphoma identified by SOX11 expression were similar to those of patients with conventional mantle cell lymphoma.
CONCLUSIONS: SOX11 mRNA and nuclear protein expression is a highly specific marker for both cyclin D1-positive and negative mantle cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880778      PMCID: PMC2770966          DOI: 10.3324/haematol.2009.010264

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  26 in total

1.  Mantle cell lymphoma: from pathology and molecular pathogenesis to new therapeutic perspectives.

Authors:  Itziar Salaverria; Patricia Perez-Galan; Dolors Colomer; Elias Campo
Journal:  Haematologica       Date:  2006-01       Impact factor: 9.941

2.  Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression.

Authors:  Christian Herens; Frédéric Lambert; Leticia Quintanilla-Martinez; Bettina Bisig; Carine Deusings; Laurence de Leval
Journal:  Blood       Date:  2008-02-01       Impact factor: 22.113

3.  Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.

Authors:  Shih-Sung Chuang; Wan-Ting Huang; Pin-Pen Hsieh; Hui-Hwa Tseng; Elias Campo; Dolors Colomer; Hongtao Ye; Chin-Li Lu; Hui-Mei Chang; Chi-Yi Cho; Shih-Hung Huang; Yin-Che Lu; Jiann-Der Wu
Journal:  Pathol Int       Date:  2006-08       Impact factor: 2.534

4.  Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.

Authors:  Y Yatabe; R Suzuki; K Tobinai; Y Matsuno; R Ichinohasama; M Okamoto; M Yamaguchi; J Tamaru; N Uike; Y Hashimoto; Y Morishima; T Suchi; M Seto; S Nakamura
Journal:  Blood       Date:  2000-04-01       Impact factor: 22.113

5.  Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies.

Authors:  T Sonoki; L Harder; D E Horsman; L Karran; I Taniguchi; T G Willis; S Gesk; D Steinemann; E Zucca; B Schlegelberger; F Solé; A J Mungall; R D Gascoyne; R Siebert; M J Dyer
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

6.  Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.

Authors:  Itziar Salaverria; Andreas Zettl; Sílvia Beà; Victor Moreno; Joan Valls; Elena Hartmann; German Ott; George Wright; Armando Lopez-Guillermo; Wing C Chan; Dennis D Weisenburger; Randy D Gascoyne; Thomas M Grogan; Jan Delabie; Elaine S Jaffe; Emili Montserrat; Hans-Konrad Muller-Hermelink; Louis M Staudt; Andreas Rosenwald; Elias Campo
Journal:  J Clin Oncol       Date:  2007-02-12       Impact factor: 44.544

7.  A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus.

Authors:  Stefan Gesk; Wolfram Klapper; José I Martín-Subero; Inga Nagel; Lana Harder; Kai Fu; Heinz-Wolfram Bernd; Dennis D Weisenburger; Reza Parwaresch; Reiner Siebert
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

Review 8.  Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.

Authors:  Pedro Jares; Dolors Colomer; Elias Campo
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

9.  Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.

Authors:  Sara Ek; Michael Dictor; Mats Jerkeman; Karin Jirström; Carl A K Borrebaeck
Journal:  Blood       Date:  2007-10-12       Impact factor: 22.113

10.  Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.

Authors:  Cinta Mestre-Escorihuela; Fanny Rubio-Moscardo; Jose A Richter; Reiner Siebert; Joan Climent; Vicente Fresquet; Elena Beltran; Xabier Agirre; Isabel Marugan; Miguel Marín; Andreas Rosenwald; Kei-Ji Sugimoto; Luise M Wheat; E Loraine Karran; Juan F García; Lydia Sanchez; Felipe Prosper; Louis M Staudt; Daniel Pinkel; Martin J S Dyer; Jose A Martinez-Climent
Journal:  Blood       Date:  2006-09-07       Impact factor: 22.113

View more
  103 in total

1.  Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis.

Authors:  Javeed Iqbal; Yulei Shen; Yanyan Liu; Kai Fu; Elaine S Jaffe; Cuiling Liu; Zhongfeng Liu; Cynthia M Lachel; Karen Deffenbacher; Timothy C Greiner; Julie M Vose; Sharathkumar Bhagavathi; Louis M Staudt; Lisa Rimsza; Andreas Rosenwald; German Ott; Jan Delabie; Elias Campo; Rita M Braziel; James R Cook; Raymond R Tubbs; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger; Timothy W McKeithan; Wing C Chan
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

Review 2.  Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era.

Authors:  Patricia Pérez-Galán; Martin Dreyling; Adrian Wiestner
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

3.  All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma.

Authors:  Amareshwar T K Singh; Andrew M Evens; Reilly J Anderson; Jennifer A Beckstead; Natesan Sankar; Antonella Sassano; Savita Bhalla; Shuo Yang; Leonidas C Platanias; Trudy M Forte; Robert O Ryan; Leo I Gordon
Journal:  Br J Haematol       Date:  2010-05-09       Impact factor: 6.998

4.  Promoter hypermethylation of SOX11 correlates with adverse clinicopathological features of human prostate cancer.

Authors:  Apiwat Pugongchai; Andrey Bychkov; Pichet Sampatanukul
Journal:  Int J Exp Pathol       Date:  2018-01-08       Impact factor: 1.925

5.  Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.

Authors:  Falko Fend; José Cabecadas; Philippe Gaulard; Elaine S Jaffe; Philip Kluin; Isinsu Kuzu; Loann Peterson; Andrew Wotherspoon; Christer Sundström
Journal:  J Hematop       Date:  2012-09       Impact factor: 0.196

6.  How to manage mantle cell lymphoma.

Authors:  M Dreyling; S Ferrero; O Hermine
Journal:  Leukemia       Date:  2014-05-23       Impact factor: 11.528

Review 7.  Diagnosis and classification of lymphoma: Impact of technical advances.

Authors:  Elaine S Jaffe
Journal:  Semin Hematol       Date:  2018-05-29       Impact factor: 3.851

8.  Blastic Transformation of a Mantle Cell Lymphoma Presenting as an Enlarging Unilateral Orbital Mass.

Authors:  Matthew A De Niear; John P Greer; Adam Seegmiller; Louise A Mawn
Journal:  Ocul Oncol Pathol       Date:  2018-11-16

9.  CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.

Authors:  Itziar Salaverria; Cristina Royo; Alejandra Carvajal-Cuenca; Guillem Clot; Alba Navarro; Alejandra Valera; Joo Y Song; Renata Woroniecka; Grzegorz Rymkiewicz; Wolfram Klapper; Elena M Hartmann; Pierre Sujobert; Iwona Wlodarska; Judith A Ferry; Philippe Gaulard; German Ott; Andreas Rosenwald; Armando Lopez-Guillermo; Leticia Quintanilla-Martinez; Nancy L Harris; Elaine S Jaffe; Reiner Siebert; Elias Campo; Sílvia Beà
Journal:  Blood       Date:  2012-12-18       Impact factor: 22.113

Review 10.  Molecular Pathogenesis of Mantle Cell Lymphoma.

Authors:  Alba Navarro; Sílvia Beà; Pedro Jares; Elías Campo
Journal:  Hematol Oncol Clin North Am       Date:  2020-07-22       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.